The AI in Business Podcast cover image

The AI in Business Podcast

AI’s Impact on the Drug Targeting Process - with Ramesh Durvasula of Lilly

Nov 7, 2023
19:16
Snipd AI
Ramesh Durvasula, Senior VP of R&D IT at Lilly, discusses AI's impact on drug targeting. AI predicts potential drugs, drives clinical trials as alternative healthcare, and enhances the work of researchers. Generative AI invents new drugs and evaluates chemists' solutions. AI analyzes scientific journals, provides deeper insights, and prompts experimentation for uncertain futures. Caution is advised in enterprise-level AI adoption.
Read more

Podcast summary created with Snipd AI

Quick takeaways

  • AI is helping pharmaceutical leaders like Lilly better predict potential drugs to invest in for bringing to market.
  • Generative AI suggests molecule ideas that chemists may be initially doubtful of, but turn out to be promising.

Deep dives

AI's Impact on Drug Targeting Process

AI is being used in the drug targeting process to understand the molecular basis of diseases and identify therapeutic agents. It helps in identifying biological targets and predicting new molecules that can address diseases.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode